Search

everythinglearnresearchcommunity

for

Search:↓

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Minoxidil boosts hair growth by activating PGHS-1.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

COX2 and ATP synthase control the size of hedgehog spines.

PGD2 stops hair growth and is higher in bald men with AGA.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Rats had lasting erectile problems after stopping a certain medication.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Hair loss drugs may cause sexual issues and infertility in men.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Oral finasteride and dutasteride may negatively affect erectile function in rats.